Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Zynerba Pharmaceuticals (ZYNE)

Annual Return

Over the past 3 years, ZYNE has had an average annual return of +265.30%, outperforming the benchmark SPY, which returned -3.87% annual.

Over the past 5 years, ZYNE has had an average annual return of -43.03%, underperforming the benchmark SPY, which returned +1.06% annual.

Over the past 10 years, ZYNE has had an average annual return of -21.09%, underperforming the benchmark SPY, which returned +12.15% annual.

Since Aug 5, 2015, ZYNE has had an average annual return of -26.54%, underperforming the benchmark SPY, which returned +11.34% annual.

202320222021202020192018201720162015
+145.40%-81.60%-12.75%-45.36%+103.34%-76.28%-19.69%+54.82%-38.03%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+26.38%-31.07%-6.69%-10.94%-12.71%-2.43%+11.94%+263.56%-4.03%+1.91%+145.40%
2022-9.37%-13.39%-9.27%-31.22%-32.14%+19.19%-0%+2.56%-37.50%-0.22%-26.28%-1.51%-81.60%
2021+5.76%+28.77%+3.47%-5.17%+28.78%-6.87%-16.62%+0.44%-4.29%-9.66%-9.67%-16.77%-12.75%
2020-16.55%-15.47%-10.11%+1.06%+35.89%-35.93%+11.28%+0.78%-12.42%+3.63%+35.24%-28.86%-45.36%
2019+76.42%-0.96%+4.41%+131.03%-1.28%+9.62%-21.84%+0.94%-29.28%+2.64%-18.43%-4.57%+103.34%
2018-3.44%-19.44%-10.78%+18.18%+3.89%-8.71%-31.73%+20.77%+1.62%-35.54%-8.37%-38.37%-76.28%
2017+10.58%+32.83%-12.23%+4.38%-11.20%-8.91%-16.91%-54.96%+31.65%+17.22%+40.51%-9.07%-19.69%

Drawdown analysis of Zynerba Pharmaceuticals (ZYNE)

The maximum drawdown for the ZYNE was -99.18%, occurring on May 19, 2023. This drawdown has not yet recovered.

The current ZYNE drawdown is -96.44%.

Since Aug 5, 2015 ZYNE has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.18%Aug 13, 20151955May 19, 2023OngoingOngoingOngoing
-15.40%Aug 10, 20151Aug 11, 20152Aug 13, 20153